Plain-English translation of NCT07723313 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Indonesia
Phase
Safety & dosing
Sponsor
PT. Prodia Stem Cell Indonesia
Collaborators
RSUP Prof. Dr. I.G.N.G. Ngoerahal
Enrollment target
~30 participants
Started
December 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.